NCT07308444

Brief Summary

As day surgery is increasingly preferred over in-hospital treatment due to feasibility and reduced economic costs, it is important to evaluate patient-related outcomes such as comfort and safety after discharge. Most previous studies on predictors for postoperative pain have not focused on postdischarge pain. In a previous study, we found that over 42% of the patients experienced severe postdischarge pain within the first 24 h after ambulatory gynaecologocal laparoscopic surgery, that is a pain score of 7-10 on the NRS. We identified four preoperative risk factors independently associated with severe postdischarge pain. We have developed a risk matrix to predict who will suffer from severe pain after surgery. The risk matrix needs to be validated in a new gynaecological patient sample. It has the potential to improve clinical practice by providing clinicians with a simple, evidence-based tool that can identify high-risk patients before surgery. The scoring takes less than one minute. Today, we do not have such an instrument at hand. The results from this project could influence current routines and treatments at Oslo University Hospital and may also apply to other patient populations and other hospitals. The primary research objective is to validate a previously developed risk matrix for postdischarge pain in gynecological day-surgery patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
487

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Aug 2021

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 19, 2021

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2022

Completed
3.4 years until next milestone

First Submitted

Initial submission to the registry

December 5, 2025

Completed
24 days until next milestone

First Posted

Study publicly available on registry

December 29, 2025

Completed
Last Updated

April 21, 2026

Status Verified

April 1, 2026

Enrollment Period

11 months

First QC Date

December 5, 2025

Last Update Submit

April 14, 2026

Conditions

Keywords

Risk matrix

Outcome Measures

Primary Outcomes (1)

  • Severe postdischarge pain

    Numerical rating scale for pain, severe pain defined as 7-10 on scale.

    Time from hospital discharge until 24 hours after end of surgery.

Secondary Outcomes (4)

  • Preoperative use of opioids

    Last four weeks prior to surgery

  • Age

    Age in years at time for surgery

  • Preoperative pain

    At time for surgery

  • Pain expectation

    After surgery

Eligibility Criteria

Age18 Years+
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsWomen by biological sex
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Women scheduled for ambulatory gynaecological laparoscopic procedures such as: ovarian cyst removal, excision of endometriosis, salpingo-oophorectomy, salpingectomy, chromopertubation, ovarian drilling for polycystic ovary syndrome, adhesion removal, diagnostic laparoscopy, oophorectomy, removal of migrated intrauterine device, sterilisation/tubal ligation.

You may qualify if:

  • Participant must be 18 years of age at the time of signing the informed consent.
  • Participant scheduled for ambulatory gynaecological laparoscopy.
  • Capable of giving written informed consent.
  • Must speak and read Norwegian.

You may not qualify if:

  • Severe psychiatric disorder, severe cognitive dysfunction.
  • Intraoperative ketamine or lidocaine infusion or regional anaesthesia.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Oslo University Hospital

Oslo, 0424, Norway

Location

MeSH Terms

Conditions

Pain

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Senior Physician, Anesthesiologist, PhD

Study Record Dates

First Submitted

December 5, 2025

First Posted

December 29, 2025

Study Start

August 19, 2021

Primary Completion

June 30, 2022

Study Completion

June 30, 2022

Last Updated

April 21, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

Locations